Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 930-938

  Ikeda, Kenji ^a   Saitoh, Satoshi ^a   Suzuki, Yoshiyuki ^a   Kobayashi, Masahiro ^a   Tsubota, Akihito ^a   Koida, Isao ^a   Arase, Yausji ^a   Fukuda, Mizuho ^a   Chayama, Kazuaki ^a   Murashima, Naoya ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Carcinogenesis; Chronic hepatitis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

ALCOHOL; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; INDOCYANINE GREEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHRONIC HEPATITIS; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0032102924     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80339-5     Document Type: Article

References (50)

1. Prince AM, Szmuness W, Michon J, Desmaille J, Diebolt G, Linhard J, et al. A case-control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer. 16:1975;376-383.
2. Ohnishi K, Iida S, Iwama S, Goto N, Nomura F, Takashi M, et al. The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma. Relation to hepatitis B surface antigen carriage. Cancer. 49:1982;672-677.
3. Lam KC, Yu MC, Leung JWC, Henderson BE. Hepatitis B virus and cigarette smoking: Risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res. 42:1982;5246-5248.
4. Hoofnagle JH, Alter HJ. Chronic viral hepatitis. Vyas GN, Dienstag JL, Hoofnagle JH. Viral Hepatitis and Liver Disease. 1984;97-113 Grune & Stratton, New York.
5. Shafritz D, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med. 305:1981;1067-1073.
6. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 312:1981;270-276.
7. Bruix J, Calvet X, Costa J, Ventura M, Bruguera M, Castillo R, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 2:1989;1004-1006.
8. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 2:1989;1006-1008.
9. Hasan F, Jeffers LJ, Medina MD, Reddy KR, Parker T, Schiff ER, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology. 12:1990;589-591.
10. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet. 335:1990;873-874.
11. Ohkoshi S, Kojima H, Tawaraya H, Miyajima T, Kamimura T, Asakura H, et al. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellullar carcinoma. Jpn J Cancer Res. 81:1990;550-553.
12. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci. 87:1990;6547-6549.
13. Kiyosawa K, Furuta S. Review of hepatitis C in Japan. J Gastroenterol Hepatol. 6:1991;383-391.
14. Dusheiko GM. Hepatitis C virus. Pounder RE. Recent Advances in Gastroenterology. 1992;195-216 Livingstone, Edinburgh: Churchill.
15. Alter MJ, Margolis HS, Krawczysnki K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 327:1992;1899-1905.
16. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 18:1993;47-53.
17. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 328:1993;1797-1801.
18. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis. 4:1984;136-146.
19. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet. i:1985;1357-1360.
20. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD, et al. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res. 46:1985;962-966.
21. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. MacSween RNM, Anthony PP, Sheuer PJ. 2nd ed. Pathology of the Liver. 1987;Churchill Livingstone, Edinburgh. ch. 17.
22. Lisker-Melman M, Martin P, Hoofnagle JH. Conditions associated with hepatocellular carcinoma. Med Clin North Am. 73:1989;999-1009.
23. Villa E, Baldini GM, Pasquinelli C, Melegari M, Cariani E, Di Chirico G, et al. Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. Cancer. 62:1988;611-615.
24. Hsieh C-C, Tzonou A, Zavitsanos X, Kaklamani E, Lan S-J, Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk: a birth order study. Am J Epidemiol. 136:1992;1115-1121.
25. Parkin DM, Stjernsward J, Muir CS. Estimates of worldwide frequency of twelve major cancers. Bull World Health Org. 62:1984;163-182.
26. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology. 6:1986;729-738.
27. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg. 211:1990;277-287.
28. Beasley R. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 61:1988;1942-1956.
29. Heywood WL, Bender TR, Lanier AP, Francis DP, McMahon BJ, Maynard JE. Serological markers of hepatitis B virus, and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos. Lancet. ii:1982;889-891.
30. Sakamoto M, Hirohashi S, Tsuda H, Ino Y, Shimosato Y, Yamasaki S, et al. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res. 48:1988;7294-7297.
31. Hadengue A, N'Dri NN, Benhamou JP. Relative risk of hepatocellular carcinoma in HBsAG positive vs. alcoholic cirrhosis. A cross-sectional study. Liver. 10:1990;147-151.
32. McMahon BJ, Alberts Sr, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequale. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Interm Med. 150:1990;1051-1054.
33. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryoji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res. 51:1991;2842-2847.
34. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med. 116:1992;97-102.
35. Ducheiko GM. Hepatocellular carcinoma associated with chronic viral hepatitis. Aetiology, diagnosis and treatment. Br Med Bull. 46:1990;492-511.
36. Gerber MA, Shieh YSC, Shim K-S, Thung SN, Demetris AJ, Schwartz J, et al. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol. 141:1992;1271-1277.
37. Obata K, Hayashi N, Motoike Y, et al. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer. 25:1980;741-747.
38. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology. 8:1988;493-496.
39. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut. 32:1991;294-298.
40. Lok ASF, Lai C, Chuang H, Lau JYN, Leung EKY, Wong LSK. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases. Hepatology. 13:1991;834-837.
41. Dusheiko GM, Di Bisceglie A, Bowyer S, Sachs E, Ritchie M, Schoub B, et al. Recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology. 5:1985;556-560.
42. Hoofnagle JH, Di Biceglie AM, Shindo M. Antiviral therapy of hepatitis C - present and future. J Hepatol. 17:1993;130-136. (Suppl 3).
43. Dusheiko GM, Peterson AC, Pitcher L, Kassianides C, Di Bisceglie AM, Song E. Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials. J Hepatol. 3:1986;199-207. (Suppl 2).
44. Korenman J, Baker B, Waggoner J, Everhart JE, Di Biceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med. 114:1991;629-634.
45. Ducheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology. 22:1995;1863-1873.
46. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ. Classification of chronic hepatitis: diagnosis, grading, and staging. Hepatology. 19:1994;1513-1520.
47. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrica. 69:1982;553-566.
48. Kaplan EL, Meier P. Nonparametic estimation for incomplete observation. J Am Stat Assoc. 53:1958;457-481.
49. Cox DR. Regression models and life tables. J R Stat Soc. 34:1972;248-275.
50. SAS/STAT User's Guide. 1988;SAS Institute Inc. Cary, NC, USA. Release 6.03 Edition.